Manal Hassanien News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Results from a small, independently funded, double-blind, active-comparator trial suggest that baricitinib could be beneficial in the treatment of lupus nephritis.

United statesSouth australiaEricf morandManal hassanienEli lillyEuropean alliance of associationsTherapeutics department at assiut universityMonash health rheumatology unitRheumatology researchEuropean allianceAdvanced therapeutics departmentAssiut universitySystemic lupus erythematosusLupus nephritisJak statAk stat signaling pathway